afamitresgene autoleucel
FDA Grants Accelerated Approval to Tecelra for Unresectable or Metastatic Synovial Sarcoma
The FDA has granted accelerated approval to afamitresgene autoleucel (Tecelra, Adaptimmune LLC), a ...
AUGUST 2, 2024

Load more